HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Consanguineous hemolytic uremic syndrome secondary to Escherichia coli O157:H7 infection treated with aggressive therapeutic plasma exchange.

Abstract
We describe the successful management of an elderly husband and wife with Escherichia coli O157:H7 associated hemolytic uremic syndrome (HUS) treated with aggressive therapeutic plasma exchange (TPE) with replacement with fresh frozen plasma. Following twelve TPEs (three 1.5 volume; nine 1 volume), the husband's platelet count increased from 45 x 10(9)/L to 183 x 10(9)/L. Following ten 1.5 volume TPEs, the wife's platelet count increased from 30 x 10(9)/L to 193 x 10(9)/L. This is the first known occurrence of E. coli O157:H7 associated HUS in an elderly husband and wife successfully treated with aggressive TPE. We conclude that early, aggressive TPE should be considered and may be life-saving for E coli O157:H7 associated HUS in the elderly.
AuthorsK A Downes, K Allen, R Sarode, R Yomtovian
JournalJournal of clinical apheresis (J Clin Apher) Vol. 16 Issue 3 Pg. 155-6 ( 2001) ISSN: 0733-2459 [Print] United States
PMID11746544 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2001 Wiley-Liss, Inc.
Topics
  • Aged
  • Escherichia coli Infections (blood, complications, therapy)
  • Escherichia coli O157
  • Female
  • Hemolytic-Uremic Syndrome (etiology, microbiology, therapy)
  • Humans
  • Male
  • Plasma Exchange
  • Platelet Count
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: